Jonathan Saltzman

Jonathan Saltzman has worked at the Boston Globe since 2002 and currently covers biotechnology and the life sciences. He previously covered the federal and state courts and then spent six years on the Spotlight Team. He was part of a team that won a George Polk Award in 2012 for a series on the state’s unusually high rate of acquittal at bench trials for drunk driving. He was also a runner-up for other awards, including a Pulitzer Prize and Goldsmith Prize for Investigative Reporting, for a series of stories about dangerous off-campus housing for college students in Boston. Saltzman, a graduate of Brooklyn College, has worked at the Providence Journal, USA Today, the Rochester Democrat & Chronicle, and the Poughkeepsie Journal. He also co-hosted a daily magazine show for the NPR station in Rhode Island. He lives in Providence.

Latest stories

Work Space

This CEO doesn’t like to be cornered

By , Globe Staff

David Schenkein’s office at Agios Pharmaceuticals reflects his life story and vision.

Japanese drug maker signs $430m deal to buy Waltham-based Visterra

By , Globe Staff

It’s the latest example of a foreign pharmaceutical company establishing a presence in the white-hot Massachusetts biotech cluster.

Bayer AG teams up with the Broad to tackle congestive heart failure

By , Globe Staff

The German drug giant will invest in a local lab to come up with treatments for the deadly condition.

Two Mass. biotechs merging to focus on kidney disease drugs

By , Globe Staff

Together, Akebia Therapeutics and Keryx Biopharmaceuticals will be worth about $1.3 billion.